Regenity Biosciences - M&A Summary, Ownership, and Business Overview

Medical ProductsCompany

Regenity Biosciences M&A Summary

Regenity Biosciences has acquired 2 companies of its own, including 2 in the last 5 years.

Regenity Biosciences has acquired in 2 countries. The Company’s most targeted sectors include medical products (100%).

Regenity Biosciences Ownership

Who owns Regenity Biosciences?

Regenity Biosciences is owned by Golub Capital, Linden Capital Partners and Northwestern Mutual Capital. It was acquired on August 1, 2019.

Is Regenity Biosciences PE-backed?

Yes. Regenity Biosciences is owned by private equity investors Golub Capital, Linden Capital Partners and Northwestern Mutual Capital.

Was Regenity Biosciences formerly PE-backed?

Yes. Regenity Biosciences was formerly owned by 1 private investor.

Regenity Biosciences Business Overview

Where is Regenity Biosciences headquartered?

Regenity Biosciences is headquartered in Paramus, New Jersey.

What sector is Regenity Biosciences in?

Regenity Biosciences is a medical products company.

When was Regenity Biosciences founded?

Regenity Biosciences was founded in 1997.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 1

Regenity Biosciences

Regenity Biosciences

115 W. Century Rd., Suite 380,
Paramus, New Jersey 07652
United States,
(201) 405-1477
www.regenity.com

Regenity Biosciences is a developer and manufacturer of collagen-based medical products used for tissue and bone repair and regeneration. Collagen Matrix, Inc. develops proprietary products that are sold to OEM customers on either a contract or private label basis across orthopedic, sports medicine, dental, and neurosurgery end markets. Collagen Matrix, Inc. also offers partnership opportunities including distribution, contract product development, and contract manufacturing services. Regenity Biosciences was founded in 1997 and is based in Paramus, New Jersey.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.4/yr) # - 1 - 1 - - 2
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
Polyganics BV 2022-10-05 - Add-on Acquisition
Groningen, Netherlands · www.polyganics.com
Sunstar's Degradable Solutions 2020-12-29 - Divestiture
Schlieren, Switzerland · www.degradablesolutions.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Medical Products 2 (100%) - - -
Total 2 - - -

By Geo

State/Country Buy Value Sell Value
Netherlands 1 - - -
Switzerland 1 - - -
Domestic - - - -
Cross-border 2 (100%) - - -
Total 2 - - -

M&A Connections

Deals
Acquired from
Strategic(s)
50%
1 (50%)

 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.